Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Toward a better understanding of T cells in cancer CANCER CELL Oh, D. Y., Fong, L., Newell, E. W., Turk, M., Chi, H., Chang, H. Y., Satpathy, A. T., Fairfax, B., Silva-Santos, B., Lantz, O. 2021; 39 (12): 1549-1552

Abstract

T cells mediate anti-tumor immune responses and are the key target of immune checkpoint therapy, but they can also promote immune tolerance. A clear understanding of the specific contributions and biology of different T cell subsets is required to fully harness the curative potential of immunotherapies. Experts discuss the state of the field and key challenges for moving forward.

View details for Web of Science ID 000731472200001

View details for PubMedID 34906313